Alnylam Pharmaceuticals shares rose 10% Friday after the company nabbed FDA approval to sell its drug Amvuttra to a larger ...

Sarepta Therapeutics said a patient taking its treatment for Duchenne muscular dystrophy has died from acute liver failure.

Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition. It is ...

Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...

My survival is based on research. With limited NIH funding, I fear that my life, and the lives of others, will be left ...

U.S. tariffs on Canada have put experts at odds over how appropriate the action was, particularly given the unaddressed ...

Novo Nordisk (NVO) stock was down ... Hollie Adams/File Photo) · REUTERS / Reuters In addition, producing CagriSema is more difficult than the current weight-loss drugs, and analysts believe ...

For Maria Rising, managing her health felt like chasing a phantom. The 30-year-old Lansing, Mich. consultant has for years ...

Roche (RHHBY) is increasing its investment into the obesity space with an up to $5.3 billion deal with Danish drugmaker Zealand Pharma (ZLDPF), the companies announced Wednesday. The deal would give ...

And given both Musk and MyPillow CEO Mike Lindell’s penchant for recreational drug use, conspiratorial thinking, and ...